BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10360438)

  • 1. Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods.
    Rosing H; van Zomeren DM; Doyle E; ten Bokkel WW; Schellens JH; Bult A; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):191-203. PubMed ID: 10360438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.
    Rosing H; Doyle E; Davies BE; Beijnen JH
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):107-15. PubMed ID: 7550966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detection.
    Bai F; Kirstein MN; Hanna SK; Iacono LC; Johnston B; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 784(2):225-32. PubMed ID: 12505770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of column temperature in the high performance liquid chromatographic analysis of topotecan in rat and dog plasma.
    Rosing H; Doyle E; Beijnen JH
    J Pharm Biomed Anal; 1996 Nov; 15(2):279-86. PubMed ID: 8933430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma.
    Vali AM; Shafaghi B; Dadashzadeh S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):205-12. PubMed ID: 15734160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography.
    Loos WJ; van Zomeren DM; Gelderblom H; Verweij J; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):99-105. PubMed ID: 11820300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography.
    de Vries NA; Ouwehand M; Buckle T; Beijnen JH; van Tellingen O
    Biomed Chromatogr; 2007 Nov; 21(11):1191-200. PubMed ID: 17582233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of the investigational anticancer drug 9-aminocamptothecin, as the lactone form and as the total of the lactone and the hydroxycarboxylate forms, in micro-volumes of human plasma.
    van Gijn R; Herben VM; Hillebrand MJ; ten Bokkel Huinink WW; Bult A; Beijnen JH
    J Pharm Biomed Anal; 1998 Sep; 17(8):1257-65. PubMed ID: 9800645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan.
    Rosing H; Herben VM; van Gortel-van Zomeren DM; Hop E; Kettenes-van den Bosch JJ; ten Bokkel Huinink WW; Beijnen JH
    Cancer Chemother Pharmacol; 1997; 39(6):498-504. PubMed ID: 9118461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma.
    Chen J; Balthasar JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):183-92. PubMed ID: 15664349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma.
    Beijnen JH; Smith BR; Keijer WJ; van Gijn R; ten Bokkel Huinink WW; Vlasveld LT; Rodenhuis S; Underberg WJ
    J Pharm Biomed Anal; 1990; 8(8-12):789-94. PubMed ID: 2100624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.
    Bullen WW; Whitfield LR; Walter GA; Brodfuehrer JI
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):141-51. PubMed ID: 7550971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Beumer JH; Rosing H; Hillebrand MJ; Nan-Offeringa LG; Foley K; Yule SM; Heck AJ; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2004; 18(23):2839-48. PubMed ID: 15517526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
    Zamboni WC; Gajjar AJ; Heideman RL; Beijnen JH; Rosing H; Houghton PJ; Stewart CF
    Clin Cancer Res; 1998 Mar; 4(3):783-9. PubMed ID: 9533548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urine.
    Loos WJ; Stoter G; Verweij J; Schellens JH
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):309-15. PubMed ID: 8738036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection.
    Loos WJ; Sparreboom A; Verweij J; Nooter K; Stoter G; Schellens JH
    J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):435-41. PubMed ID: 9252060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
    Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
    Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and sensitive determination of the new antitumor drug CKD-602 in human plasma by liquid chromatography.
    Cho JY; Seo HB; Yu KS; Bae KS; Yi SY; Jang IJ; Shin SG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 784(1):25-31. PubMed ID: 12504179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.